Biote (BTMD) Restructuring Costs (2021 - 2022)

Biote (BTMD) posted quarterly Restructuring Costs of $1.2 million for Q1 2022, up 1932.73% year-over-year from $58560.0 in Q1 2021, and down 49.15% on a QoQ basis from $2.3 million in Q4 2021.

Biote (BTMD) Restructuring Costs (2021 - 2022) Analysis & Trends

Biote (BTMD) has reported Restructuring Costs for 2 consecutive years, with $1.2 million the latest figure, recorded in Q1 2022.

  • In Q1 2022, Restructuring Costs rose 1932.73% year-over-year to $1.2 million; the TTM figure through Mar 2022 stood at $4.3 million (changed N/A YoY), while the FY2021 annual figure was $3.1 million, changed N/A from the prior year.
  • Restructuring Costs came in at $1.2 million for Q1 2022 at Biote, down from $2.3 million in the prior quarter.
  • The five-year high for Restructuring Costs was $2.3 million in Q4 2021, with the low at $58560.0 in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 Biote 5,970.00 2.82 Mn 30.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2022 1.19 Mn
Dec 31, 2021 2.34 Mn
Sep 30, 2021 262,487.00
Jun 30, 2021 459,768.00
Mar 31, 2021 58,560.00